Faecal calprotectin as a diagnostic test for IBD in children in primary care

Faecal calprotectin as a diagnostic test for IBD in children in primary care - Calprotectin study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34153

Enrollment

218

Registered

2010-10-22

Start date

2011-06-14

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease inflammatory bowel disease ulcerative colitis

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1.Age 4-18 years 2.Diarrhoea >= 2 weeks or >= 2 episodes of diarrhoea in the past 6 months or recurrent abdominal pain (>= 2 episodes of abdominal pain in the past 6 months) 3.Informed consent

Exclusion criteria

Exclusion criteria: 1.Previously established diagnosis of chronic organic gastrointestinal disease 2.A complete evaluation in the past year for abdominal symptoms, including endoscopy 3.Chronic use of antibiotics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or oral corticosteroids. 4.Difficulty in understanding questionnaires due to cognitive impairment or language problems

Design outcomes

Primary

Measure	Time frame
Sensitivity, specificity and ROC-curve of faecal calprotectin. Test results of faecal calprotectin will be compared to a diagnosis of IBD after 12 months follow-up. Outcome of care defined as optimal care, delay of diagnosis, and unnecessary endoscopy are secondary endpoints.	—

Secondary

Measure	Time frame
Health related quality of life	—

Countries

Netherlands

Outcome results